A Phase 1 Study of CPI-1205, a Small Molecule Inhibitor of EZH2, in Patients with B-Cell Lymphomas - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 1 Study of CPI-1205, a Small Molecule Inhibitor of EZH2, in Patients with B-Cell Lymphomas

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
Constellation
Protocol Number
Constellation 1205-01
Cancer Diagnosis
To Learn More Call
201-510-0910